Technology Bundle ID: TAB-903

Full-Length cDNA Clone Representing the Consensus Sequence of the RNA Genome of a Human Norovirus (strain MD145-12) That Encodes Biologically Active Proteins

Request More Info
Primary Inventors: 
Gael Belliot (NIAID)
Lisbeth Kim Green (NIAID), Stanislav Sosnovtsev (NIAID)
Therapeutic Area: 
Infectious Disease
Research Materials
Institute or Center: 

The invention provides for a full-length cloned cDNA copy of the RNA genome of a predominant norovirus strain (Genogroup II.4) designated MD145-12 that was associated with human gastrointestinal illness. The noroviruses, which were formerly known as "Norwalk-like" viruses are estimated to cause 23 million cases of acute gastroenteritis in the USA each year. The virus has been designated into category B of the CDC biodefense-related priority pathogens because it can be used as an agent of bioterrorism. The subject cDNA clone of the virus encodes proteins of the MD145-12 strain that, when expressed in vitro, exhibit properties that would be expected from those produced by the original infectious virus. This cDNA clone is presently the only source to obtain norovirus proteins to facilitate studies aimed at developing control strategies such as vaccines and therapeutic drugs.


EIR Application

Research Material -- Patent protection is not being pursued for these technologies

Research Material -- Patent protection is not being pursued for this technology

License Status

The cDNA clone for norovirus strain MD145-12 is available for licensing via a biological material license (BML).


Jun 1, 2008

Data Source: